linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company Background  
Jagsonpal Pharmaceuticals Ltd.
 
Industry : Pharmaceuticals & Drugs House : Jagsonpal
BSE Code 507789
ISIN Demat INE048B01035
Book Value 36.07
NSE Code JAGSNPHARM
Dividend Yield % 1.03
Market Cap 16142.65
P/E 29.16
EPS 8.32
Face Value 2  
 
Incorporation Year 17-08 1978  
Registered Office Innov8 3rd Floor, Plot No. 211,Okhla Phase-3, , New Delhi,
Delhi-110020 .
ISINNO INE048B01035  
Phone 011-46181100 / 46109900  
E-mail cs@jagsonpal.com
URL www.jagsonpal.com
Industry Pharmaceuticals & Drugs  
Chairman Harsha Raghavan  
Managing Director Manish Gupta  
Company Secretary Pratham Rawal  
Listing BSE,NSE  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.